From Fidelity: McLean Capital Management resume
Post# of 150964
(Total Views: 442)
Posted On: 03/13/2025 6:13:02 AM
From Fidelity:
McLean Capital Management resumes coverage for Cytodyn with NEUTRAL recommendation.
Investars Analyst Actions - public
3:12 PM ET Mar-11-2025
On March 11, 2025 McLean Capital Management resumed coverage for Cytodyn (CYDY.NaE) with a NEUTRAL recommendation.
McLean Capital Management resumes coverage for Cytodyn with NEUTRAL recommendation.
Investars Analyst Actions - public
3:12 PM ET Mar-11-2025
On March 11, 2025 McLean Capital Management resumed coverage for Cytodyn (CYDY.NaE) with a NEUTRAL recommendation.
(7)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼